Prosecution Insights
Last updated: April 19, 2026

United Therapeutics Corporation

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18106782 TREPROSTINIL ILOPROST COMBINATION THERAPY ARMSTRONG, SUSANNAH SIPPLE 1616 Final Rejection Feb 07, 2023
18077038 METHODS AND COMPOSITIONS FOR IMPROVING ENDOTHELIAL CELL BARRIER KNIGHT, TERESA E 1634 Non-Final OA Dec 07, 2022
17967255 TREPROSTINIL ADMINISTRATION BY INHALATION SCHMITT, MICHAEL J 1629 Non-Final OA Oct 17, 2022
17164693 EXTRACELLULAR VESICLES WITH ENHANCED POTENCY MARTIN, PAUL C 1653 Final Rejection Feb 01, 2021

Managing United Therapeutics Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month